Gateway Investment Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,158	Closed	-$380K	–	508
2024 Q4	$380K	Buy	1,158 +373	+48%	+$127K	﹤0.01%	410
2024 Q3	$263K	Sell	785 -90	-10%	-$28.6K	﹤0.01%	466
2024 Q2	$239K	Sell	875 -39	-4%	-$11.3K	﹤0.01%	470
2024 Q1	$316K	Sell	914 -21	-2%	-$6.91K	﹤0.01%	438
2023 Q4	$302K	Sell	935 -140	-13%	-$43.9K	﹤0.01%	436
2023 Q3	$385K	Buy	1,075 +44	+4%	+$17K	﹤0.01%	406
2023 Q2	$391K	Buy	1,031 +381	+59%	+$155K	﹤0.01%	405
2023 Q1	$311K	Buy	650 +114	+21%	+$53.4K	﹤0.01%	436
2022 Q4	$225K	Buy	+536	New	+$216K	﹤0.01%	504
2022 Q3	–	Sell	-912	Closed	-$451K	–	512
2022 Q2	$451K	Buy	912 +307	+51%	+$160K	0.01%	433
2022 Q1	$341K	Hold	605	–	–	﹤0.01%	476
2021 Q4	$457K	Buy	605 +54	+10%	+$40.4K	﹤0.01%	429
2021 Q3	$411K	Buy	551 +63	+13%	+$47.2K	﹤0.01%	436
2021 Q2	$314K	Sell	488 -13	-3%	-$7.91K	﹤0.01%	476
2021 Q1	$286K	Buy	501 +5	+1%	+$2.96K	﹤0.01%	483
2020 Q4	$289K	Sell	496 -21	-4%	-$12K	﹤0.01%	477
2020 Q3	$266K	Buy	517 +51	+11%	+$25.8K	﹤0.01%	470
2020 Q2	$210K	Buy	+466	New	+$206K	﹤0.01%	510